US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Autism Report is to understand the market and pipeline status of the drugs around the Autism to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... key objective of the Brain Tumor Report is to understand the market and pipeline status of the drugs around the Brain Tumor to explore the generic development opportunities, licensing opportunities and to gain competitive advantage ...  |  read more...
USD 2,000
Fibromyalgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Fibromyalgia Report is to understand the market and pipeline status of the drugs around the Fibromyalgia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... A key objective of the Glioblastoma Multiforme (GBM) Report is to understand the market and pipeline status of the drugs around the Glioblastoma Multiforme (GBM) to explore the generic development opportunities, licensing opportunities and to ...  |  read more...
USD 2,000
Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Glioma Report is to understand the market and pipeline status of the drugs around the Glioma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Malignant Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... key objective of the Malignant Glioma Report is to understand the market and pipeline status of the drugs around the Malignant Glioma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage ...  |  read more...
USD 2,000
Medulloblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Medulloblastoma Report is to understand the market and pipeline status of the drugs around the Medulloblastoma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... A key objective of the Restless Legs Syndrome Report is to understand the market and pipeline status of the drugs around the Restless Legs Syndrome to explore the generic development opportunities, licensing opportunities and to ...  |  read more...
USD 2,000
Tourette Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... key objective of the Tourette Syndrome Report is to understand the market and pipeline status of the drugs around the Tourette Syndrome to explore the generic development opportunities, licensing opportunities and to gain competitive advantage ...  |  read more...
USD 2,000
Global Rehabilitation Robots Market 2016-2020
1/13/2016 | published by: TechNavio - Infiniti Research Ltd.
... in improving an individual's functional recovery from strokes. The stroke is a major health problem worldwide and is the main cause of disability in most western countries. Typically, a large number of hours are spent ...  |  read more...
USD 2,000
Global Biopolar Disorder Therapeutics Market 2015-2019
12/16/2015 | published by: TechNavio - Infiniti Research Ltd.
... affects the personal, social, and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. ...  |  read more...
USD 2,500
India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contr
12/1/2015 | published by: Azoth Analytics
... Summary The Indian neuropsychiatry market is driven by the consumer awareness of health care resulting in access for early treatment along with increasing cases of mental disorders. Indian Neuropsychiatry Market is a growing market with ...  |  read more...
USD 2,200
Global Central Nervous System (CNS) Biomarkers Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Central Nervous System (CNS) Biomarkers basics: definitions, classifications, applications and industry chain overview; ...  |  read more...
USD 2,850
Global Neuroendoscopy Industry 2015 Market Research Report
12/3/2015 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Neuroendoscopy basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Opium Withdrawal Syndrome Global Clinical Trials Review, H2, 2015
12/23/2015 | published by: GlobalData
... report provides top line data relating to the clinical trials on Opium Withdrawal Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2015
11/25/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dementia Associated With Alzheimer's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Anxiety Disorders - Pipeline Review, H2 2015
12/23/2015 | published by: Global Markets Direct
... therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Opioids Drugs Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Opioids Drugs basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Global Precision Medicine Market
11/17/2015 | published by: BIS Research
... Obama in January, 2015, a large number of research and development has been taken for the development of precise drugs, targeted therapeutics, and laboratory tests. Presently, the main focus of the government initiatives is toward ...  |  read more...
USD 3,799
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H2, 2015
12/16/2015 | published by: GlobalData
... Disorder (ADHD) clinical trials scenario. This report provides top line data relating to the clinical trials on Attention Deficit Hyperactivity Disorder (ADHD). Report includes an overview of trial numbers and their average enrollment in top ...  |  read more...
USD 2,500
Guillain-Barre Syndrome - Pipeline Review, H2 2015
12/9/2015 | published by: Global Markets Direct
... therapeutic development for Guillain-Barre Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Brain (Head) Trauma Global Clinical Trials Review, H2, 2015
12/9/2015 | published by: GlobalData
... report provides top line data relating to the clinical trials on Brain (Head) Trauma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
General Anxiety Disorder - Pipeline Review, H2 2015
11/25/2015 | published by: Global Markets Direct
... information on the therapeutic development for General Anxiety Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10